Skip to main content
Figure 5 | BMC Neuroscience

Figure 5

From: Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease

Figure 5

Mean total number of hind leg slips over three sessions in each post-injection test for each Injection/Treatment group. Vertical error lines represent ± SEM. Significant difference (p < 0.05) between the control or either of the two PQ/ Ubisol – Q10 groups and the PQ3 group in each injection test phase are designated by * and between the control and the PQ/Ubisol-Q10 8 weeks group and the PQ3 in the second injection phase by ^.

Back to article page